David Zidar, MD

Showing    of 4 results

Clinical Trial at UH Seeks to Improve Outcomes for TAVR Patients

Two anti-platelet drugs studied for their effect on platelet function and immune activation post-procedure Innovations in Cardiovascular Medicine & Surgery - Fall 2018  David A. Zidar, MD, PhD Transcatheter aortic valve replacement (TAVR) has...

Statins Under-Prescribed in the Young with Severe Dyslipidemia

Harrington Heart & Vascular Institute Innovations | Winter 2017

Making the Case for CT CORONARY CALCIUM SCORING

Harrington Heart & Vascular Institute Innovations | Spring 2016

Asking Questions Giving Options

New clinical trials open for advanced LV heart failure, chelation therapy and renal denervation for treatment-resistant hypertension Guilherme Oliveira, MD Sahil Parikh, MD David Zidar, MD, PHD Harrington Heart & Vascular Institute Innovations...

Results are loading...
Back to Top